Tag: Johnson & Johnson

Cramer says look to these 4 stocks to go with your high-flying tech names

Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion

Here’s our monthly update on all 31 portfolio stocks, including 3 on the buy list

Trump tariff fallout: Some industries grapple with lingering effects one year later

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi

FDA vaccine head will step down in April after string of controversial decisions

Russia’s war on Ukraine puts women off having children — and that could spell economic disaster

FDA chief Marty Makary says ‘everything should be over-the-counter’ unless drug is unsafe or addictive

Stock futures are little changed after S&P 500 and Dow notch worst day since October: Live updates